ICOSLG and melanoma: Liu et al. demonstrated that ICOSL enhances tumor susceptibility to T-cell therapy and may be able to tap into the potential of the large number of tumor-specific T cells in the melanoma patients by activating B7H-mediated signal transduction within the tumor milieu [27].